Xarelto still being sold in market without any Antidote

Written by admin

Xarelto, from Bayer AG and Johnson & Johnson, and Eliquis, sold by Bristol-Myers Squibb and Pfizer is an oral anticoagulant drug which is marketed by Janssen Pharmaceutical. It was approved by the Food and Drug Administration (FDA) in November 2011, as one of a number of new blood thinners designed to prevent strokes due to atrial fibrillation. There are several severe complication associated with the drug including, brain hemorrhaging, rectal bleeding, intestinal bleeding, blood clots, pulmonary embolism, and deep vein thrombosis. Xarelto is typically prescribed by cardiologists and hematologists for the treatment of blood clotting disorders. Unlike warfarin, there is no known antidote to stop bleeding caused by this medication leading many doctors to hold off on prescribing the drugs. Despite all these complications and risk of no antidote the drug is one of the top selling medicines in the market.
Johnson & Johnson and Janssen Pharmaceuticals are recklessly promoting the drug as safe despite warn doctors and patient about the risk and complications cause by the drug due to the lack of its reversal agent. Thousand of xarelto lawsuit are filed against Xarelto manufacturers allege that the company should have thoroughly investigated potential Xarelto antidotes, which may have allowed doctors to reverse the blood thinning effects of the medication. According to the plaintiffs manufacturers withheld information about the lack of an antidote along with the prescribing information. If the doctors know about severe risk of developing hemorrhages without the antidote, they could have prescribed the medication more discriminately and could have monitored patients more intently to evaluate their hemorrhage risk.
Xarelto associated with severe adverse events include internal bleeding, fatal brain and stomach bleeds. There is allegedly no antidote to stop uncontrolled bleeding, which can lead Xarelto to cause someone to bleed to death. Recently few months back the FDA Postpone Approval of Xarelto Antidote. The agency needs additional information on the drug’s manufacturing and needs to review changes Portola made to its post-marketing commitments. As per a report released by the the Louisiana court, lawsuits against drug manufacturers, Xarelto claims have now reached 9,000 across the country. Xarelto has been used by more than 9,000,000 people around the world and it is associated with severe health complications. The FDA has to take action to protect consumers from dangerous medicines and ban these life threatening medicines in the U.S market.
If you or your love ones are facing fatal complication or serious bleeding event after taking Xarelto can take a legal action against the company. He/she can claim for reimbursement money against complication or any loss. We have an experience attorneys group who Investigating Xarelto lawsuits Bleeding Problems. We evaluate your case free of cost unless we win the case for you. Contact for free and confidential case review.

About the author


Leave a Comment